Loading clinical trials...
Loading clinical trials...
Non-interventional study aiming to provide data on the subjective effects of antipsychotic medication assessing subjective well-being and global functioning of patients with Schizophrenia under antipsychotic medication. Moreover it aims to assess their adherence to the treatment and will investigate whether there is any correlation of these factors with the clinical condition of these patients.
Age
18 - 65 years
Sex
ALL
Healthy Volunteers
No
Research Site
Agrinio, Greece
Research Site
Alexsandroupoli, Greece
Research Site
Argos, Greece
Research Site
Arta, Greece
Research Site
Athens, Greece
Research Site
Crete, Greece
Research Site
Drama, Greece
Research Site
Edessa, Greece
Research Site
Elefsina, Greece
Research Site
Giannitsá, Greece
Start Date
March 1, 2009
Primary Completion Date
October 1, 2009
Completion Date
October 1, 2009
Last Updated
December 9, 2010
600
ACTUAL participants
Lead Sponsor
AstraZeneca
NCT07455929
NCT06740383
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions